Tender Details
Ref No 24691370
Document

Tender Notice

Bidding

Not specified

Short Description

Order 0326 Acquisition Of Reagents For Emergencies H-Q Cancer Program
Deadline *
Date 23 Feb 2026
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location Bolivia
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.

Similar Tenders

  • Ref No: 9868439
  • Location: United States

Open Ended School Based Health Center Services Sbhc Rfp

  • Deadline: 31 Dec 2099
  • Ref No: 8259327
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Cre 2 5 Mg N1

  • Deadline: 10 May 2026
  • Ref No: 8260726
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Tab 10 Mg

  • Deadline: 10 May 2026
  • Ref No: 5310892
  • Location: Germany

Drug Contracts With An Option To Join

  • Deadline: 01 May 2026
  • Ref No: 5301821
  • Location: Bulgaria

Delivery Of Medicinal Products Which Are Included In Appendix 2 Of The Pds For The Needs Of Umbal Kanev Ad

  • Deadline: 27 May 2027
  • Ref No: 5396790
  • Location: Germany

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient L

  • Deadline: 27 Apr 2026
  • Ref No: 4717233
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possib

  • Deadline: 31 Dec 2026
  • Ref No: 4722689
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possib

  • Deadline: 31 Dec 2026
  • Ref No: 6479528
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility O

  • Deadline: 31 Dec 2026
  • Ref No: 4720419
  • Location: Germany

Conclusion Of An Open House Framework Agreement Direct Personnel Placement

  • Deadline: 25 Mar 2026

Security Assessment Of Facilities

  • Deadline: 07 Dec 2026
  • Ref No: 5226107
  • Location: Germany

Medicines With The Active Ingredient Combination Vilanterol Umeclidinium Bromide And Fluticasone Furoate Atc R03Al08

  • Deadline: 31 Mar 2026
WhatsApp Chat